Table 1.
Demographic characteristics of participants at baseline.
| Baseline demographics | (N = 13) |
|---|---|
| Age | 13–17 years, M = 15.2, SD = (1.4) |
| Sex | |
| Males | 4 |
| Females | 9 |
| Race | |
| Caucasian | 7 (54%) |
| African American | 3 (23%) |
| Biracial/MultiEthnic | 2 (15%) |
| Hispanic | 1 (8%) |
| Medical diagnoses | |
| Major depressive disorder | 11 (85%) |
| Depressive disorder NOS | 2 (15%) |
| Co-morbid diagnoses | |
| Attention deficit/hyperactivity disorder | 2 (15%) |
| Anxiety disorder, NOS | 2 (15%) |
| Medications | |
| None | 7 (54%) |
| Selective serotonin reuptake inhibitor | 5 (38.5%) |
| Fluoxetine | 4 (30%) |
| Sertraline | 1 (8%) |
| Stimulants (also on SSRIs) | 3 (23%) |
| Body mass index—CDC category | |
| Healthy weight | 2 (23%) |
| Overweight | 5 (38.5%) |
| Obese | 5 (38.5%) |